ATE241630T1 - Verfahren zur herstellung von ucn-01 - Google Patents

Verfahren zur herstellung von ucn-01

Info

Publication number
ATE241630T1
ATE241630T1 AT99125341T AT99125341T ATE241630T1 AT E241630 T1 ATE241630 T1 AT E241630T1 AT 99125341 T AT99125341 T AT 99125341T AT 99125341 T AT99125341 T AT 99125341T AT E241630 T1 ATE241630 T1 AT E241630T1
Authority
AT
Austria
Prior art keywords
ucn
producing
acidified
producing ucn
solution
Prior art date
Application number
AT99125341T
Other languages
English (en)
Inventor
Akihito Nagamura
Hidenori Aoki
Mitsutaka Kino
Toshimitsu Takiguchi
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Application granted granted Critical
Publication of ATE241630T1 publication Critical patent/ATE241630T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT99125341T 1998-12-22 1999-12-21 Verfahren zur herstellung von ucn-01 ATE241630T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10364369A JP2000186092A (ja) 1998-12-22 1998-12-22 Ｕｃｎ−０１の製造法

Publications (1)

Publication Number Publication Date
ATE241630T1 true ATE241630T1 (de) 2003-06-15

Family

ID=18481646

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99125341T ATE241630T1 (de) 1998-12-22 1999-12-21 Verfahren zur herstellung von ucn-01

Country Status (6)

Country Link
US (1) US6197955B1 (de)
EP (1) EP1020471B1 (de)
JP (1) JP2000186092A (de)
AT (1) ATE241630T1 (de)
CA (1) CA2293023A1 (de)
DE (1) DE69908288T2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6887864B2 (en) 2002-03-12 2005-05-03 Hoffmann-La Roche Inc. Azepane derivatives
EP1651612B9 (de) 2003-07-22 2012-09-05 Astex Therapeutics Limited 3,4-disubstituierte 1h-pyrazol-verbindungen und deren verwendung als cyclin-abhängige kinase (cdk) und glycogen synthase kinase-3 (gsk-3) modulatoren
AR054425A1 (es) 2005-01-21 2007-06-27 Astex Therapeutics Ltd Sales de adicion de piperidin 4-il- amida de acido 4-(2,6-dicloro-benzoilamino) 1h-pirazol-3-carboxilico.
US8404718B2 (en) 2005-01-21 2013-03-26 Astex Therapeutics Limited Combinations of pyrazole kinase inhibitors
WO2006077428A1 (en) * 2005-01-21 2006-07-27 Astex Therapeutics Limited Pharmaceutical compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62220196A (ja) 1986-03-20 1987-09-28 Kyowa Hakko Kogyo Co Ltd 新規物質ｕｃｎ―０１
WO1989007105A1 (en) 1988-02-04 1989-08-10 Kyowa Hakko Kogyo Co., Ltd. Staurosporin derivatives
ES2136103T3 (es) * 1992-06-22 1999-11-16 Kyowa Hakko Kogyo Kk Procedimiento para la preparacion de derivados de estaurosporina.

Also Published As

Publication number Publication date
JP2000186092A (ja) 2000-07-04
US6197955B1 (en) 2001-03-06
EP1020471B1 (de) 2003-05-28
DE69908288D1 (de) 2003-07-03
CA2293023A1 (en) 2000-06-22
DE69908288T2 (de) 2004-04-08
EP1020471A1 (de) 2000-07-19

Similar Documents

Publication Publication Date Title
ATE121066T1 (de) Verfahren zur herstellung von 6,12-dihydro-6- hydroxy-cannabidiol und dessen anwendung zur herstellung von trans-delta-9- tetrahydrocannabinol.
DE69908998D1 (de) Verfahren zur Herstellung von Kohlenstoff
DE69101775T2 (de) Verfahren zur Herstellung von Wasserstoffperoxid.
DE68916086D1 (de) Verfahren zur Herstellung von Kohlenstoff/Kohlenstoff-Verbundstoffen.
DE69007800D1 (de) Verfahren zur fermentativen Herstellung von L-Arginin.
DE68909627T2 (de) Verfahren zur Herstellung von Aktivkohle.
DE69521175T2 (de) Verfahren zur Herstellung von Xanthangummi
DE69020172T2 (de) Verfahren zur Herstellung von epsilon-Caprolactam.
ATE101144T1 (de) Verfahren zur herstellung von cyclischen sulfaten.
DE68908576T2 (de) Verfahren zur Herstellung von Aktivkohle.
DE69903443D1 (de) Kontinuierliches Verfahren zur Herstellung von optisch reinem (S)-3-Hydroxy-gamma-Butyrolacton
ATE241630T1 (de) Verfahren zur herstellung von ucn-01
DE69620539D1 (de) Verfahren zur Reinigung von Thrombomodulin
DE69228648D1 (de) Verfahren zur Herstellung von komplementären, bipolaren Transistoren
ATE277919T1 (de) Verfahren zur herstellung von baccatin iii- derivativen
DE3685337D1 (de) Verfahren zur herstellung von amiden unter verwendung von mikroorganismen.
ATE174966T1 (de) Verfahren zur herstellung von biotin
DE59807664D1 (de) Verfahren zur herstellung von 3-cyano-2,4-dihalogen-5-fluor-benzoesäuren
DE59905165D1 (de) Verfahren zur Herstellung von Orthoestern
DE69021001T2 (de) Enzymatisches Verfahren zur Herstellung von L-Serin.
DE68920358D1 (de) Verfahren zur Herstellung von Schwefelwasserstoff.
DE59809481D1 (de) Verfahren zur Herstellung von Aminocyanacetamid
ATE231157T1 (de) VERFAHREN ZUR HERSTELLUNG VON EPIPODOPHYLLOTOXINE-4'-DEMETHYL-4'-PHOSPHAT-2ß, ß-BIS PENTAFLUORPHENOXYACETYL-4ß,6ß-ETHYLIDEN- BETA-D- GLUCOSID UND SEINE SALZEN
DE69812858T2 (de) Verfahren zur Herstellung von (R)-3-Hydroxy-4-Butyrolacton, nützlich für die Herstellung von (R)-Carnitin
DE59400715D1 (de) Diskontinuierliches katalytisches Verfahren zur Herstellung von Polyamid-6.6

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties